Treatment of primary cutaneous B-cell lymphoma with radiotherapy.
Primary cutaneous B-cell lymphomas (PCBCL) are rare and constitute 5-10% of all cutaneous lymphomas. In patients with PCBCL presenting with solitary or localized skin lesions, radiotherapy is the preferred treatment. Two patients who were treated with 4 MeV electrons, both obtained remission for 51 months. Unfortunately, at the last visit one patient relapsed on the border of the radiotherapy field and was re-treated with a generous irradiation field in 2004. Complete response was obtained again. Thus, for localized PCBCL, radiotherapy alone is an effective treatment.
Ulutin
H Cüneyt
HC
Department of Radiation Oncology, Gülhane Military Medicine Academy, Turkey.
Oztürk
Bekir
B
Ongürü
Onder
O
Kuzhan
Okan
O
Arpaci
Fikret
F
Ozet
Ahmet
A
D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D012878:Skin Neoplasms / Q000532:radiotherapy*